BCMA CRISPR/Cas9 Lentivirus (Integrating) - 500 µl x 2
The BCMA CRISPR/Ca9 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudo-typed lentiviral particles that are ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses contain a CRISPR/Cas9 gene, driven by an EF1A promoter, and 5 sgRNA (single guide RNA) targeting human BCMA (B-cell maturation antigen) driven by a U6 promoter (see Table 1 for sgRNA sequences). The integrating lentivirus integrates randomly into the cellʹs genome to express both the Cas9 and sgRNAs. Simultaneous expression of Cas9 and BCMA sgRNA allows the generation of BCMA-knockout cells with one single transduction step. The lentiviruses also contain a puromycin selection marker.
List of sgRNA sequences in the BCMA CRISPR/Cas9 Lentivirus.
Gene Target: Primer ID: sgRNA Sequence:
TNFRSF17 (BCMA) TNFRSF17-1 CCTCTAACATGTCAGCGTTA
TNFRSF17 (BCMA) TNFRSF17-2 TGTCAACTTCGATGTTCTTC TNFRSF17 (BCMA) TNFRSF17-3 C
Supplier Catalog Number |
78893 |
---|---|
Shipping conditions |
Dry ice |
Storage Temperature |
-80°C |
Supplier name |
BPS Bioscience |
From
€1,195.00
Total
€1,195.00
In stock
- SKU
- P00915635::500 µl x 2
No surprise after checkout. All fees included
Your satisfaction first: door delivery with guaranteed replacement
Dedicated Scientific Support to select & use
Recently Viewed Products
of